Cresset Asset Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,016
Closed -$318K 1751
2024
Q3
$318K Buy
5,016
+266
+6% +$19.2K ﹤0.01% 1775
2024
Q2
$321K Buy
4,750
+412
+9% +$28.8K ﹤0.01% 1674
2024
Q1
$344K Buy
4,338
+129
+3% +$10.5K ﹤0.01% 1513
2023
Q4
$327K Sell
4,209
-75
-2% -$5.55K ﹤0.01% 1446
2023
Q3
$301K Buy
4,284
+560
+15% +$41.8K ﹤0.01% 1434
2023
Q2
$297K Buy
+3,724
New +$269K ﹤0.01% 1524
2021
Q4
Sell
-5,501
Closed -$352K 1124
2021
Q3
$352K Buy
5,501
+159
+3% +$10K ﹤0.01% 777
2021
Q2
$336K Buy
5,342
+180
+3% +$11.3K ﹤0.01% 725
2021
Q1
$295K Buy
+5,162
New +$279K ﹤0.01% 684
2019
Q2
Sell
-1,354
Closed -$40K 483
2019
Q1
$40K Buy
1,354
+217
+19% +$6.15K ﹤0.01% 843
2018
Q4
$29K Buy
+1,137
New +$39.4K ﹤0.01% 633

Other funds holding ACHC

Cresset Asset Management's ACHC Position: Q4 2024 in Review

Cresset Asset Management sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 5,016 shares — an estimated $318K sold.

Cresset Asset Management first reported a position in ACHC in Q4 2018 and held it in 11 quarters. The position peaked at $352K in Q3 2021. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • Cresset Asset Management reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 5,016 Acadia Healthcare shares in Q4 2024, an estimated $318K.
  • Cresset Asset Management first reported a position in Acadia Healthcare in Q4 2018 and held it in 11 quarters.
  • Cresset Asset Management's Acadia Healthcare position peaked at $352K in Q3 2021.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.